Skip to content

Echo IQ Ltd Sustainability Reports

Echo IQ Limited develops artificial intelligence-driven diagnostics tools and proprietary clinical software designed to improve decision-making in cardiology. Its flagship EchoSolv platform assists clinicians in detecting structural heart conditions, including aortic stenosis and heart failure, through automated risk assessment of echocardiographic data.

Sector: Technology & telecommunications

Country: Australia

Exchange: Australian Securities Exchange

LEI: 984500C02FCE7ADF6A81

3 reports from 2022 to 2024